Newron Pharmaceuticals S.p.A.
NWPHF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6,933 | $7,897 | $6,338 | $7,713 |
| Short-Term Investments | $2,893 | $4,291 | $6,261 | $9,426 |
| Receivables | $42,423 | $2,512 | $2,530 | $2,026 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4,636 | $3,437 | $2,652 | $3,297 |
| Total Curr. Assets | $61,104 | $20,080 | $19,652 | $24,241 |
| Property Plant & Equip (Net) | $834 | $342 | $405 | $472 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,970 | $4,515 | $5,809 | -$472 |
| Total NC Assets | $2,804 | $4,857 | $6,214 | $472 |
| Other Assets | $0 | $0 | $0 | $6,781 |
| Total Assets | $63,908 | $24,937 | $25,866 | $31,494 |
| Liabilities | – | – | – | – |
| Payables | $2,465 | $2,868 | $2,019 | $1,879 |
| Short-Term Debt | $13,414 | $0 | $22,277 | $12,409 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | -$12,580 |
| Other Curr. Liab. | $4,949 | $590 | $967 | $791 |
| Total Curr. Liab. | $23,506 | $5,377 | $28,926 | $16,762 |
| LT Debt | $36,243 | $48,530 | $25,753 | $34,218 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2,028 | $1,725 | $885 | -$274 |
| Total NC Liab. | $38,944 | $50,392 | $26,848 | $34,218 |
| Other Liabilities | $0 | $0 | $0 | $1,476 |
| Cap. Leases | $812 | $321 | $385 | $445 |
| Total Liabilities | $62,450 | $55,769 | $55,774 | $52,456 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $12,081 | $0 |
| Common Stock | $3,992 | $3,809 | $3,569 | $3,569 |
| Retained Earnings | $10,685 | -$14,719 | -$21,396 | -$12,237 |
| AOCI | $0 | -$19,922 | $0 | $0 |
| Other Equity | $15,300 | $0 | $3,131 | $14,999 |
| Total Equity | $1,458 | -$30,832 | -$29,908 | -$20,962 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $63,908 | $24,937 | $25,866 | $31,494 |
| Net Debt | $42,724 | $40,633 | $41,692 | $38,914 |